Rare diseases
Investigational molecules
Locations
Dr.-Boehringer-Gasse 5-11, Meidling, 1120 Vienna, Austria
Research activity includes idiopathic pulmonary fibrosis, progressive pulmonary fibrosis, and systemic sclerosis with lung involvement, alongside bronchiectasis. The portfolio also extends to long-term management of fibrotic lung conditions and related respiratory impairment.
Key interest is centered on respiratory function, disease progression, and chronic pulmonary symptom burden.
Boehringer Ingelheim RCV GmbH & Co. KG runs clinical trials in conditions such as Obesity, Portal hypertension, Systemic scleroderma, Type 2 diabetes mellitus, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Study on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease
AustriaStudy on BI 685509 for Adults with Systemic Sclerosis to Assess Effects on Lung Function and Symptoms
AustriaStudy on the Effectiveness of Survodutide for Weight Loss in Patients with Type 2 Diabetes and Obesity
BelgiumStudy on the Effectiveness of Survodutide for Weight Loss in Adults with Obesity Without Diabetes
BelgiumLong-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
AustriaStudy to Test BI 765845 for Patients with Heart Attack
CzechiaStudy on BI 907828 for Patients with Advanced Biliary Tract, Pancreatic, Lung, or Bladder Cancer
AustriaStudy on the Effects of BI 685509 for Patients with Liver Cirrhosis and Portal Hypertension After First Decompensation Event
AustriaStudy to Evaluate the Effectiveness of Spesolimab in Treating Patients with Netherton Syndrome
AustriaStudy to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa
AustriaStudy on BI 685509 and Empagliflozin for Patients with Portal Hypertension in Compensated Cirrhosis
AustriaStudy on Long-Term Safety and Efficacy of BI 1291583 in Patients with Bronchiectasis
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
